Related Experiment Videos
Dopamine D1 and adenosine A1 receptors form functionally interacting heteromeric complexes
S Ginés1, J Hillion, M Torvinen
1Department of Biochemistry and Molecular Biology, University of Barcelona, 08028 Barcelona, Spain.
Summary
Adenosine A(1) receptors (A(1)R) and dopamine D(1) receptors (D(1)R) form heteromers in the brain, explaining their antagonistic interactions. This A(1)R/D(1)R heteromerization is crucial for receptor desensitization and signaling modulation.
Area of Science:
- Neuroscience
- Molecular Pharmacology
- Cell Biology
Background:
- Antagonistic interactions between adenosine A(1) receptors (A(1)R) and dopamine D(1) receptors (D(1)R) have been observed in the brain.
- The molecular mechanisms underlying these receptor interactions require further elucidation.
Purpose of the Study:
- To investigate the molecular basis of the antagonistic interactions between A(1)R and D(1)R.
- To determine if A(1)R and D(1)R form heteromers and how this affects receptor signaling and desensitization.
Main Methods:
- Cotransfection of mouse fibroblast cells with human A(1)R and D(1)R or D(2)R cDNAs.
- Coimmunoprecipitation assays to detect receptor heteromerization.
- Confocal laser microscopy for colocalization studies.
- Agonist pretreatment to assess effects on heteromerization, coclustering, and cAMP accumulation.
Main Results:
- A(1)R and D(1)R, but not A(1)R and D(2)R, were found to coimmunoprecipitate, indicating selective heteromerization.
- A high degree of A(1)R and D(1)R colocalization was observed in both cotransfected cells and cortical neurons.
- A(1)R agonist pretreatment induced A(1)R/D(1)R coclustering, which was blocked by combined A(1)R and D(1)R agonist pretreatment.
- Combined D(1)R and A(1)R agonist pretreatment significantly reduced D(1)R agonist-induced cAMP accumulation.
Conclusions:
- A(1)R/D(1)R heteromerization is a likely molecular basis for the antagonistic modulation of D(1)R signaling by A(1)R in the brain.
- A(1)R/D(1)R heteromers play a role in desensitization mechanisms and receptor trafficking, as evidenced by the blockade of agonist-induced coclustering and cAMP accumulation.